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The success of Pichia pastoris as a heterologous expression system lies predominantly in the impressive yields that
can be achieved due to high volumetric productivity. However, low specific productivity still inhibits the potential
success of this platform. Multi-(gene) copy clones are potentially a quick and convenient method to increase
recombinant protein titer, yet they are not without their pitfalls. It has been more than twenty years since the first
reported use of multi-copy clones and it is still an active area of research to find the fastest and most efficient
method for generating these strains. It has also become apparent that there is not always a linear correlation
between copy number and protein titer, leading to in-depth investigations into how to minimize the negative
impact of secretory stress and achieve clonal stability.
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Background
Pichia pastoris has, in recent years, become one of the
more popular platforms for heterologous protein expres-
sion, surpassing Saccharomyces cerevisiae as the preferred
yeast recombinant expression system [1]. The popularity
of P. pastoris stems from high volumetric productivity,
resulting in cell densities up to 130 g L-1, with a lack of
fermentative products [2] and a more favorable glycosyla-
tion pattern with N-linked oligosaccharides chains of no
more than 20 links [3]. However, despite these high cell
densities low specific productivity is still an issue, resulting
in extensive research to improve titer levels. One of the
best established methods for increasing titer is to increase
the number of cognate genes with the intention that this
will lead to an increase in transcription and translation of
the desired gene. Theoretically, a clone with two identical
copies of a gene under the control of an identical pro-
moter should produce twice as much protein. In practice
however, the results are more mixed and in many cases
the actual titer is below what would be predicted from the
number of genes inserted (see below).* Correspondence: r.aw08@imperial.ac.uk; k.polizzi@imperial.ac.uk
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reproduction in any medium, provided the orRegardless of the mixed success of multi-copy clones,
many groups continue to use this as a key strategy for
increasing heterologous protein yield. The research into
the development of multi-copy strains can focus on two
areas. The first (and easiest) experiments look at the
quickest and most efficient way of generating multi-copy
strains and whether or not this is successful in increasing
yield for the particular protein being expressed. The sec-
ond strategy investigates the effect of these multi-gene
copies on the physiology of the cell, including stress on
the secretory pathway and potential genetic instability.Generating multi-copy clones
Depending on the design and method of transformation,
it is possible to integrate multiple copies of a heterol-
ogous gene into the P. pastoris genome.
One of the easiest methods for generating a strain car-
rying multiple cognate genes is to use different selection
markers for sequential integration (Figure 1, top left) [4].
This will require repeat transformations, each with a dif-
ferent selection marker. The drawback of this method is
that copy number can only correlate to the number of se-
lection markers available (either antibiotic or auxotrophic
markers) and the cost can increase significantly if multiple
antibiotics are used.
Gene insertion through a single crossover event can lead
to multiple copies being integrated in approximately 1%
of all transformants, often in a head-to-tail orientation [4].al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Methods to generate multi-copy clones. Schematic representation of some of the more common methods used to create
multi-copy clones. Multiple selection markers can be used when a gene is integrated into the genome through a vector with a single selection
marker. This method is limited to the number of selection markers available (either antibiotic or through complementation to auxotrophic genes).
Additionally, each vector must be transformed sequentially and the labor associated with selection increases with each additional gene. In vitro
multimerization uses the pAO815 vector that isolates an expression cassette containing the promoter, gene of interest and transcription
terminator region and ligating this in a head-to-tail orientation into a linearized vector. Copy number is determined prior to integration into the
genome. Direct selection on high concentrations of antibiotic uses a single transformation with a vector containing either G418 or Zeocin™
and selection directly onto high concentrations of the antibiotic. This results in jackpot colonies (over 10 copies of the gene) in less than 1% of all
clones. Posttransformational vector amplification (PTVA) uses a single vector for transformation (containing either the G418 or Zeocin™
resistance marker). Selection is originally on a low concentration of the corresponding antibiotic, but the cells are increasingly subjected to higher
concentrations. Only colonies that have multiple copies of the resistance gene (and therefore multiple copies of the heterologous gene) will be
able to survive on the highest concentrations. Jackpot colonies are reported in 6% of all clones tested. Integration into the rDNA locus with
PTVA utilizes the repeat sequence of the rDNA (appearing 16 times in GS115), which can prevent tandem head-to-tail integration. Multi-copy
clones are generated using PTVA.
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ing; however this can often be labor intensive. The use of
antibiotics, such as Geneticin® (G418) and Zeocin™, and
their corresponding antibiotic resistance genes can de-
crease the workload associated with screening for multi-
copy clones. The user is able to select multiple integrants
by modulating the antibiotic concentration (Figure 1, bot-
tom right), something which cannot be done when using
auxotrophic markers for selection. Some of the firststudies that created multi-copy clones used a two-step se-
lection method to identify multiple integrants [5-7]. Initial
selection for clones containing the Geneticin® resistance
gene was carried out using complementation to HIS4 and
selection on medium lacking histidine. A second round of
selection was then carried out using plates containing
G418 at varying concentrations (0.5, 1.0, 1.5, 2.0 mg L-1)
[8]. Theoretically, only clones with increased copies of the
antibiotic resistance gene would be able to survive on the
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tors containing a fully functional Tn903kanr gene allows
for selection directly onto G418, which decreases the
workload involved. Furthermore, this reduces the vector
size as the HIS4 gene is no longer required; thereby in-
creasing transformation efficiency as smaller vectors inte-
grate more frequently into the genome [9]. Along with the
modified Tn903kanr, the increasingly prevalent use of the
Zeocin™ resistance gene as a selection marker (where one-
step selection is the norm) makes creating multi-copy
clones easier [10].
Due to the popularity of multi-copy clones, commer-
cial kits are available that aim to increase the number of
heterologous genes integrating into the genome. From
the commercial kits, the idea of in vitro multimerization
before genomic integration has developed (Figure 1, top
right). The in vitro method uses the pAO815 plasmid to
amplify only the expression cassette (promoter, gene of
interest, transcription terminator) [11], so that the entire
expression construct will only have one copy of the HIS4
gene, origin of replication and ampicillin resistance marker
(for selection in Escherichia coli) [12]. The disadvantage of
this method is that it results in a large plasmid, which is
notoriously difficult to transform successfully into P.
pastoris [9]. Thus, there is a limit to the number of copies
of the gene of interest that can be integrated using this ap-
proach. A modified version of this procedure can be imple-
mented using the popular pPICZ plasmid and its Zeocin™
resistance marker. This may be a more advantageous strat-
egy, as it has been noted that the use of HIS4 as a selection
marker does not always result in stable integration [4].
An alternative commercial product relies on a color-
based selection marker, which does not increase the prob-
ability of multiple cognate genes but instead makes the
screening process easier. This system utilizes an ADE2
auxotroph strain, where the color of the colonies relates
to the copy number [13]. The ADE2 gene catalyzes the
sixth step in the production of purine nucleotides by en-
coding phosphoribosylaminoimidazole carboxylase [14]
and a mutation in ADE2 will lead to an accumulation of
purine precursors, resulting in a red color. Therefore, the
more copies of ADE2 that are complemented into the
genome, the less purine precursors that will build up and
the whiter the colony will appear.
In 2008, Sunga et al. described a new method for the
production of multi-copy clones, posttransformational vec-
tor amplification (PTVA, Figure 1, bottom center) [15].
PTVA works on the basis that increasing the concentration
of antibiotic (particularly Zeocin™ or G418) in a stepwise
manner results in an increase in the percentage of multi-
copy clones and, in particular, “jackpot” clones with more
than 10 copies of the integrated vector. From an initial
transformation, single colonies are selected from a plate
containing 100 μg mL-1 Zeocin™. These are then spottedonto another Zeocin™ plate at the same antibiotic con-
centration and left to grow for 3–5 days. Each spot is
then replicated onto another plate containing increasing
concentrations of Zeocin™ (e.g. 200, 300, 500, 1000 and
2000 μg mL-1 Zeocin™ were used in the original paper).
Since Zeocin™ resistance is obtained by the production
of a protein that sequesters the antibiotic (rather than
an enzyme which catalyzes its degradation), resistance
to higher concentrations of Zeocin™ requires an in-
creased amount of resistance protein. The theory be-
hind PTVA is that increased levels of resistance protein
will be due to increased copies of the entire vector [15].
PTVA has been adopted by other groups, with one
reporting a total of 52 copies of the PIP gene integrated
through this method [16]. Additionally, PTVA has also
been adapted for integration into the ribosomal DNA
(rDNA) locus [17], which has 16 identical repeat regions
in P. pastoris [18], any or all of which can serve as a site
for integration (Figure 1, bottom left).
The unpredictability of multi-copy clones
Multi-(gene) copy strains have been used since the early
1990s [4,19]. Figure 2 summarizes the results from a
wide range of investigations where multi-copy clones
were generated and analyzed. It is apparent that while in
many cases an increased copy number results in an in-
crease in product, the relationship is not always linear
and there are also instances where a higher copy number
leads to a reduction in heterologous protein. Based on
the studies to date, the choice of promoter, the presence
of a secretion signal and the strain utilized can have an
impact on the feasibility of using multi-copy clones for
increased titer production.
The first use of multi-copy clones was in 1991 by Clare
et al. in the production of tetanus toxin fragment C as an
intracellular protein [5]. In this study, increasing the num-
ber of gene copies from a single copy to 14 copies resulted
in a 10% increase in heterologous protein yield [25]. The
production of the heterologous protein relied on the alco-
hol oxidase (AOX) 1 promoter, which has been noted to
impact the success of multi-copy clones. With this pro-
moter, two types of integration are possible. A double
crossover event removes the native AOX1 gene, resulting
in a strain with the methanol utilization slow (MutS)
phenotype. A single crossover, preserves the AOX1 gene,
resulting in a Mut+ phenotype [25]. In the MutS pheno-
type, growth will be significantly reduced on methanol,
which could make more resources available for protein
production. The study by Clare et al. evaluated the impact
of both methanol utilization phenotypes when expressing
tetanus toxin fragment C and found lower yields in the
Mut+, supporting this hypothesis (Figure 2) [5].
Vassileva et al. found a significant linear relation-
ship (R2 = 0.98) between gene dosage and titer in the
Figure 2 The impact of multi-copy clones on titer levels. Expression or activity levels were determined from published data and are
presented as a ratio compared to the expression or activity of a single copy strain (calculated by dividing by the equivalent value of a single copy
clone). A star (*) indicates that values were estimated. Tetanus toxin fragment C utilized different integration sites (HIS4 or AOX1) by linearizing the
vector with different restriction sites prior to transformation. Intracellular expression using the AOX1 promoter. Samples were grown in either
shake flasks or bioreactors [5]. Mouse epidermal growth factor (mEGF) was expressed as a secreted protein using the AOX1 promoter. Samples
were grown in shake flasks and bioreactors [19]. Hepatitis B surface antigen (HBsAg) was expressed intracellularly under the GAP promoter in
shake flasks [12]. Trypsinogen (TRY1) was expressed extracellularly using the GAP promoter or AOX1 promoter [20]. Miniproinsulin (MPI) was
expressed using the AOX1 promoter as a secreted protein [21]. Necator americanus secretory protein (Na-ASP1) was co-expressed with varying
copies of protein disulfide-isomerase (PDI) to determine the impact of chaperone coexpression. All variants were secreted and expressed under
the AOX1 promoter [22]. Human superoxide dismutase (hSOD) was expressed intracellularly under the GAP promoter. Integration occurred at the
rDNA locus with multi-copy clones generated by PTVA. Stability was observed for 28 generations, indicated by the diagonal stripes [17]. Porcine
insulin precursor (PIP), using PTVA to generate multi-copy clones, was expressed under the AOX1 promoter and secreted [16]. Instability was
observed in clones (under inducible conditions) with a copy number above 6, indicated by the horizontal stripes [23]. Interleukin and human
growth hormone proteins were fused with HSA, IL-HSA and HG-HSA respectively, and co-expressed with PDI or BiP. The fusion proteins were
secreted under the control of the AOX1 promoter [24].
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four copies resulting in a four-fold increase in yield [26].
This was under the control of the constitutive glyceralde
hyde-3-phosphate dehydrogenase (GAP) promoter, which
is significantly weaker than the AOX1 promoter. It is pos-
sible that reduced burden on the cell may account for the
linear correlation. Additionally, Marx et al. reported that
for the production of human Cu/Zn superoxide dismutase
(hSOD) integrated in to the rDNA locus, there was a
strong correlation between titer and copy number [17]. In
each case, the proteins were expressed intracellularly,
which prevents additional stress on the secretory pathway
and perhaps explains the relationship between increasing
gene copy number and higher titer.
In many industrial settings producing the protein as a
secreted product is desirable in order to ease down-
stream processing. Therefore, it is important to examine
the effect of protein secretion on the yield obtained frommulti-copy clones. Clare et al. expressed the mouse epi-
dermal growth factor (mEGF) as a secreted protein using
the AOX1 promoter [19]. For growth in both shake
flasks and bioreactors, titer increases with increasing
copy number, although this is less prominent when the
strains are grown in bioreactors (Figure 2). An increase
in titer with multi-copy clones was also observed when
expressing miniproinsulin (MPI) extracellularly under the
control of the AOX1 promoter. A direct correlation be-
tween copy number and titer was observed, with five cop-
ies of the MPI gene resulting in a six-fold increase relative
to a one copy clone and an 11-copy clone resulting in a
13-fold increase [21].
Nevertheless, such direct correlations between copy
number and titer have not always been observed [20].
Proteins targeted to the secretory pathway often show evi-
dence of secretion saturation, whereby increasing gene
copy number does not always equate to higher titer [20].
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copy number for different proteins (most likely due to
the stability of the individual protein and the difficulty
of folding [27]), the trend of plateauing yield is the same.
When Marx et al. expressed secreted human serum albu-
min (HSA), only clones with up to seven copy numbers
showed a similarly high correlation. After this, titer plat-
eaued irrespective of the number of genes integrated [26].
Inan et al. expressed Necator americanus secretory protein
(Na-ASP1) and found titer capped at three copies [22].
Further evidence of increasing copy number having a det-
rimental effect on yield was also demonstrated by Zhu
et al., who determined that an increase in copies of the
porcine insulin precursor (PIP) up to 12 copies had a posi-
tive effect on titer but thereafter any further increase in
copy number resulted in not only a reduction in titer but,
also, a reduction in growth [16].
Biochemical basis of reduced yield in multi-copy clones
The evidence for secretion saturation raises a fundamen-
tal concern about the impact of increased traffic through
the secretory pathway. In 2004, Hohenblum et al. [20]
compared the response of a recombinant strains with
one, two or three copies of the TRY1 gene under differ-
ent promoters. It was noted that increasing copy number
did not increase titer when using the GAP promoter, but
when using the AOX1 promoter, titer increased from a
single copy clone to two copies and then reduced dra-
matically (to levels lower than with a one copy clone)
with a three copy clone (Figure 2). As AOX1 is a highly
active promoter, Hohenblum et al. suggested that the
amount of protein produced was causing stress on the
secretory pathway, leading to the upregulation of the un-
folded protein response (UPR) and resulting in degrad-
ation of the protein. [20,28]. The UPR is a signaling
pathway activated in response to the accumulation of
unfolded proteins in the endoplasmic reticulum (ER).
UPR activation results in the upregulation of a number
of genes, with the ultimate aim of restoring ER homeo-
stasis. An excess of unfolded or misfolded protein causes
the dissociation of Kar2p (also known as BiP) from Ire1p
and allows these membrane proteins to oligomerize [29].
The Ire1p, which is an ER-located transmembrane kin-
ase and endoribonuclease, then initiates the splicing of
HAC1 mRNA, which activates the upregulation of key
UPR genes [30-32]. Among these are chaperones such
as Kar2p and protein disulfide-isomerase (PDI), which
increase the folding capacity in the ER [33]. The UPR has
severe negative impacts on protein production. Under pro-
longed signaling, the ER-associated degradation (ERAD)
pathway is activated [34,35], resulting in retrotranslocation
of misfolded protein to the cytosol for degradation by the
proteasome [36-39], reducing the overall yield. Proteins
that are poor folders are more likely to induce the UPRand to activate the ERAD, which is one explanation as to
why secretion saturation is reached at different copy num-
bers in different systems [27]. A simple way to improve
yield is to fuse the protein of interest with a protein that
folds and secretes well, such as HSA [24,40,41]. Because
HSA can reach such high titers (up to 10 g L-1), the impact
on the secretory pathway is significantly reduced, as trans-
lation is not impeded by the need to produce additional
chaperones to help with folding [27]. By increasing the
ease through which the proteins can move through the
secretory pathway, this will theoretically prevent the up-
regulation of the UPR [42,43].
Attempts to control the UPR have also been investi-
gated in an effort to alleviate cellular stress and increase
protein production [32,44]. One such method is the co-
expression of chaperone proteins alongside the protein
of interest, which has been reported to reduce the effects
of the UPR. In single copy clones of P. pastoris, it has
been reported that synergistically expressing Kar2p/PDI
can increase secretion levels by up to 6.5 times [45].
When using multi-copy clones, co-expressing PDI alone
appears to result in a consistent increase in protein titer.
However, co-expressing Kar2p alone is a less successful
strategy (Figure 2) [24]. Inan et al. showed that there was a
strong correlation between the number of copies of PDI
integrated into a strain and the amount of secreted Na-
ASP1. However, there was still evidence of intracellular ac-
cumulation of Na-ASP1 regardless of the number of PDI
genes included, suggesting that overexpressing a chaperone
does not completely overcome the blockage in the secre-
tory pathway [22]. Another strategy has been to overex-
press the main transcriptional regulator of the UPR,
Hac1p, which has been successfully demonstrated in S. cer-
evisiae and Aspergillus niger var. awamori [46,47]. In P.
pastoris overexpression of Hac1p in a single copy strain
yielded mixed results depending on the heterologous pro-
tein in question [30].
The problem of strain stability
In addition to secretion saturation, there have been a
handful of papers that have made reference to the prob-
lems of genetic instability in multi-copy clones. One of
the advantages of using P. pastoris is the ease with which
it can be genetically modified [2]. Nevertheless, it is per-
haps this highly recombinogenic nature that results in
unstable clones. Theoretically, an organism that so read-
ily accepts DNA can lose it just as fast. In 1998, Ohi
et al. reported that a clone with two copies of HSA inte-
grated into the HIS4 locus and grown for 163 hours (83
generations) resulted in 0.1% of cells losing the foreign
gene [48]. In both S. cerevisiae and Yarrow lipolytica, it
was determined that the generation of multi-copy clones
through tandem integration could result in the excision of
the integrated genes through a loop-out method (Figure 3)
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lar mechanisms, the assumption is that recombination of
this variety can also occur.
In both S. cerevisiae and Y. lipolytica integrating into
the rDNA locus has been shown to prevent recombin-
ation between homologous regions, resulting in higher
copy number stability [50,53]. The same integration into
the rDNA locus was established in P. pastoris in 2006 by
Steinborn et al. [54]. While in S. cerevisiae, the number
of rDNA repeats ranges from around 100–200 copies
[55], this is significantly reduced in P. pastoris GS115,
with only 16 copies identified. Thus, the number of in-
dependent integrations that can occur at unique rDNAFigure 3 Loop out recombination. Through the highly recombinogenic
head-to-tail orientation. This will create repeat regions of homology which
a two copy clone there is the potential for at least five loop out regions (b
for a three copy clone.loci is also reduced [18]. In 2009, Marx et al. combined
rDNA locus-directed integration with PTVA to generate
multi-copy clones and determined that these were stable
for up to 28 generations (Figure 2) [17].
In the same year, Zhu et al. undertook one of the most
intensive investigations into the stability of multi-copy
clones to date, after generating a wide range of strains
with varying copy number through PTVA [23]. Real-time
quantitative PCR was used to determine the copy number
of clones containing 1, 6, 12, 19 and 29 copies of the PIP
gene, both pre-induction (growth on glycerol) and post in-
duction (growth on methanol). It was determined that
clones with less than six copies of the heterologous genenature of P. pastoris multiple copies of the vectors can integrate in a
can recombine to remove either the whole or parts of the vector. For
ased on the design of the vector) and this can increase to at least 11
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showed copy number instability when induced with metha-
nol (Figure 2). Stability was observed for all clones when
grown on a glycerol-based medium.
To combat the highly recombinogenic nature of P.
pastoris, Näätasaari et al. have developed the ku70 dele-
tion strain to prevent non-homologous recombination
by knocking out the main protein responsible for non-
homologous end joining in double-stranded DNA break
repair [56]. This method intends to prevent the vector
from integrating anywhere other than the desired target
location. However, Näätasaari et al. also show that the ku70
deletion strains have increased stability, as no changes in
copy number were observed after 72 hours of methanol in-
duction when the protein was expressed intracellularly. Des-
pite this, it is important to note that the maximum number
of copies used in this investigation was eight, whereas the
first copy number to exhibit instability in the systematic in-
vestigation by Zhu et al. was 12, suggesting that it would be
of interest to determine the stability of strains with higher
copy numbers. It would also be of interest to determine
whether secretory stress impacts the stability of the strain
by expressing secreted proteins in this strain.
Conclusions and future perspectives
The draw of increasing titer through the use of multi-
copy clones is so enticing that, despite having originally
been described over 20 years ago, it is an aspect that is
still being investigated in depth today. The fact that the
choice of promoter, strain, method of expression and
heterologous protein of interest can impact the titer pro-
duced by multi-copy clones implies that these variables
may have an impact on the stability of the strain. With
proteins expressed intracellularly, there will be no stress
on the secretory pathway; thus preventing the impact of
the UPR. Theoretically, if the cells are not undergoing
such an intense cellular stress then natural selection will
not force the selection of clones with a lower copy number.
It is important to note that recombination between regions
of homology is likely to still occur but the propensity for
lower copy clones may not be as high. However the advan-
tage of P. pastoris as a heterologous expression platform
lies in the reduced downstream processing required for se-
creted proteins due to the minimal amount of native pro-
teins expressed. Thus, it is vital that improvements to the
functionality of multi-copy clones with extracellular ex-
pression are developed.
The advent of better selection markers and more
stable strains, as well as the implementation of corre-
sponding methods that have been effective in other
yeast, make the possibility of creating stable multi-copy
clones more promising. Several additional strategies to
decrease instability and/or secretory stress could be ex-
plored in the future. For example, it has been reportedin S. cerevisiae that integrating into the transposable
element Ty1, present in approximately 30 to 40 copies
within the genome, results in even higher stability than
using the rDNA locus [51,52]. It would be interesting to
investigate whether there is an equivalent Ty1 gene that
can be used for generating more stable multi-copy
clones in P. pastoris.
The current work aiming to modulate the upregulation
of the UPR may turn out to be a critical aspect for im-
proving yields from multi-copy clones. Many groups have
investigated ways to reduce the effects of the UPR, pre-
dominantly by co-expressing chaperones such as PDI or
Kar2p, e.g. [22,57] or by overexpressing Hac1p [44]. How-
ever, these approaches are often protein specific and do
not work in a general scheme; thus the method has to be
individually tailored for the particular protein in question.
Ultimately, it may be necessary to consider a more general
strategy that can be applied to all proteins of interest.
One such strategy is to consider ER expansion, a method
that has been evaluated in S. cerevisiae [58]. ER expansion
has been proven to independently alleviate UPR stress in
the absence of co-expressing folding chaperones. If homo-
logs of the relevant proteins (ino2/4) can be determined in
P. pastoris, then increasing the size of the ER may mean
that secretion saturation is reached at a higher capacity,
resulting in increased titer for all proteins. Theoretically, a
cell that is able to deal with additional nascent protein
without inducing the UPR, could achieve higher yields.
Another potential generic method for increasing pro-
tein yield was discussed in a 2013 paper by Larsen et al.,
which identified “super-secretor” phenotypes of P. pastoris
that, independent of the recombinant proteins expressed,
resulted in increased titer [59]. One such mutant strain,
beta-galactosidase supersecretion (bgs) 13, was identified
as a key strain that could prove to be pivotal in increasing
the capacity for protein expression. Out of five heterol-
ogous proteins tested, bgs13 knockout strains showed in-
creased protein production for four of the proteins. As all
of the BGS genes identified are not related to the secretory
pathway, it suggests that these strains are increasing titer
by manipulating other factors. It would be of interest to
observe how these strains would behave with multiple
gene copies and whether stress on the secretory pathway
was still observed.
For multi-copy clones to be fully utilized, further re-
search is required to ensure that methods to generate
these strains are quick and effective, the resulting strains
are stable and that the cell is capable of dealing with the
additional heterologous proteins. The story of multi-
copy clones is already more than twenty years old, but it
is far from over. The potential of this method can only
be fully discovered as researchers attempt to understand
more about the basic toolbox of P. pastoris, perhaps
something that has been ignored for far too long.
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